Literature DB >> 21343800

Breast cancer screening and problem solving using mammography, ultrasound, and magnetic resonance imaging.

Regina J Hooley1, Liva Andrejeva, Leslie M Scoutt.   

Abstract

Although mammography is the mainstay of early breast cancer detection, it has known limitations, particularly in women with dense breasts. As a result, additional imaging modalities, including ultrasound and contrast-enhanced magnetic resonance imaging, are also being used to supplement mammography in the early detection of occult breast cancer. This article reviews the indications and efficacy of mammography, ultrasound, and magnetic resonance imaging as both screening and diagnostic tools.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21343800     DOI: 10.1097/RUQ.0b013e31820e15ac

Source DB:  PubMed          Journal:  Ultrasound Q        ISSN: 0894-8771            Impact factor:   1.657


  13 in total

1.  Quantitative assessment of tumor angiogenesis using real-time motion-compensated contrast-enhanced ultrasound imaging.

Authors:  Marybeth A Pysz; Ismayil Guracar; Kira Foygel; Lu Tian; Jürgen K Willmann
Journal:  Angiogenesis       Date:  2012-04-26       Impact factor: 9.596

Review 2.  Current and future trends in photoacoustic breast imaging.

Authors:  Srirang Manohar; Maura Dantuma
Journal:  Photoacoustics       Date:  2019-06-30

3.  Advanced Breast Imaging Availability by Screening Facility Characteristics.

Authors:  Christoph I Lee; Andy Bogart; Rebecca A Hubbard; Eniola T Obadina; Deirdre A Hill; Jennifer S Haas; Anna N A Tosteson; Jennifer A Alford-Teaster; Brian L Sprague; Wendy B DeMartini; Constance D Lehman; Tracy L Onega
Journal:  Acad Radiol       Date:  2015-04-04       Impact factor: 3.173

4.  Availability of Advanced Breast Imaging at Screening Facilities Serving Vulnerable Populations.

Authors:  Christoph I Lee; Andy Bogart; Jessica C Germino; L Elizabeth Goldman; Rebecca A Hubbard; Jennifer S Haas; Deirdre A Hill; Anna Na Tosteson; Jennifer A Alford-Teaster; Wendy B DeMartini; Constance D Lehman; Tracy L Onega
Journal:  J Med Screen       Date:  2015-06-15       Impact factor: 2.136

5.  Semi-anthropomorphic photoacoustic breast phantom.

Authors:  Maura Dantuma; Rianne van Dommelen; Srirang Manohar
Journal:  Biomed Opt Express       Date:  2019-10-29       Impact factor: 3.732

6.  Commentary on: Incidental Breast Cancers Identified in a One-Stop Symptomatic Breast Clinic.

Authors:  Jeong Eon Lee; Jung-Hyun Yang; Seok Jin Nam
Journal:  J Breast Cancer       Date:  2011-06-18       Impact factor: 3.588

7.  Early detection of breast cancer using total biochemical analysis of peripheral blood components: a preliminary study.

Authors:  Udi Zelig; Eyal Barlev; Omri Bar; Itai Gross; Felix Flomen; Shaul Mordechai; Joseph Kapelushnik; Ilana Nathan; Hanoch Kashtan; Nir Wasserberg; Osnat Madhala-Givon
Journal:  BMC Cancer       Date:  2015-05-15       Impact factor: 4.430

8.  AGR3 in breast cancer: prognostic impact and suitable serum-based biomarker for early cancer detection.

Authors:  Stefan Garczyk; Saskia von Stillfried; Wiebke Antonopoulos; Arndt Hartmann; Michael G Schrauder; Peter A Fasching; Tobias Anzeneder; Andrea Tannapfel; Yavuz Ergönenc; Ruth Knüchel; Michael Rose; Edgar Dahl
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

Review 9.  Why the Gold Standard Approach by Mammography Demands Extension by Multiomics? Application of Liquid Biopsy miRNA Profiles to Breast Cancer Disease Management.

Authors:  Pavol Zubor; Peter Kubatka; Karol Kajo; Zuzana Dankova; Hubert Polacek; Tibor Bielik; Erik Kudela; Marek Samec; Alena Liskova; Dominika Vlcakova; Tatiana Kulkovska; Igor Stastny; Veronika Holubekova; Jan Bujnak; Zuzana Laucekova; Dietrich Büsselberg; Mariusz Adamek; Walther Kuhn; Jan Danko; Olga Golubnitschaja
Journal:  Int J Mol Sci       Date:  2019-06-13       Impact factor: 5.923

10.  Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening.

Authors:  Vera Kloten; Birte Becker; Kirsten Winner; Michael G Schrauder; Peter A Fasching; Tobias Anzeneder; Jürgen Veeck; Arndt Hartmann; Ruth Knüchel; Edgar Dahl
Journal:  Breast Cancer Res       Date:  2013-01-15       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.